BlossomHill Therapeutics, Inc. (BLSM)
NMS · Healthcare · Biotechnology
$15.81
+1.35%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$502.5M
Shares Outstanding
31.8M
Exchange
NMS
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (11.5M) | (14.1M) | (22.1M) | (24.7M) |
| Net Income | (10.5M) | (13.2M) | (21.0M) | (23.8M) |
| Diluted EPS | $-0.50 | $-0.64 | $-1.01 | $-0.78 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Operating Income | (36.4M) | (64.0M) |
| Net Income | (30.7M) | (60.6M) |
| Diluted EPS | $-1.47 | $-3.69 |